Targeting survivin (BIRC5) with YM155 for the treatment of head and neck squamous cell carcinoma

被引：0
|
作者：
Kumar, Bhavna [1 ]
Yadav, Arti [1 ]
Teknos, Theodoros N. [1 ]
Kumar, Pawan [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-5604
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5604
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Epigenetic Changes at the Birc5 Promoter Induced by YM155 in Synovial Sarcoma
    Mika, Aleksander
    Luelling, Sarah E.
    Pavek, Adriene
    Nartker, Christopher
    Heyneman, Alexandra L.
    Jones, Kevin B.
    Barrott, Jared J.
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (03):
  • [2] Targeting of Survivin Pathways by YM155 Inhibits Cell Death and Invasion in Oral Squamous Cell Carcinoma Cells
    Zhang, Wei
    Liu, Yuan
    Li, Yu Feng
    Yue, Yun
    Yang, Xinghua
    Peng, Lin
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 38 (06) : 2426 - 2437
  • [3] Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma
    Benaiges, Ester
    Ceperuelo-Mallafre, Victoria
    Guaita, Sandra
    Maymo-Masip, Elsa
    Madeira, Ana
    Gomez, David
    Hernandez, Victor
    Vilaseca, Isabel
    Merma, Carla
    Leon, Xavier
    Terra, Ximena
    Vendrell, Joan
    Aviles-Jurado, Francesc Xavier
    Fernandez-Veledo, Sonia
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (07): : 1752 - 1765
  • [4] Canine squamous cell carcinoma cell lines with high expression of survivin are sensitive to survivin inhibitor YM155
    Miyamoto, R.
    Kurita, S.
    Tani, H.
    Ikeda, T.
    Ishizaka, M.
    Saima, H.
    Kobayashi, M.
    Tamura, K.
    Bonkobara, M.
    VETERINARY JOURNAL, 2018, 240 : 31 - 36
  • [5] YM155 Reverses Cisplatin Resistance in Head and Neck Cancer by Decreasing Cytoplasmic Survivin Levels
    Kumar, Bhavna
    Yadav, Arti
    Lang, James C.
    Cipolla, Michael J.
    Schmitt, Alessandra C.
    Arradaza, Nicole
    Teknos, Theodoros N.
    Kumar, Pawan
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (09) : 1988 - 1998
  • [6] Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma
    Troiano, Giuseppe
    Guida, Agostino
    Aquino, Gabriella
    Botti, Gerardo
    Losito, Nunzia Simona
    Papagerakis, Silvana
    Pedicillo, Maria Carmela
    Ionna, Franco
    Longo, Francesco
    Cantile, Monica
    Pennella, Antonio
    Lo Russo, Lucio
    Di Gioia, Giovanni
    Mariggio, Maria Addolorata
    Lo Muzio, Lorenzo
    Pannone, Giuseppe
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (09)
  • [7] Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expression
    Lamers, Fieke
    Schild, Linda
    Koster, Jan
    Versteeg, Rogier
    Caron, Huib N.
    Molenaar, Jan J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (05) : 763 - 771
  • [8] Targeting abundant survivin expression in liposarcoma: subtype dependent therapy responses to YM155 treatment
    Vay, Christian
    Schlunder, Philipp M.
    Dizdar, Levent
    Esposito, Irene
    Ghadimi, Markus P. H.
    Knoefel, Wolfram T.
    Krieg, Andreas
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (03) : 633 - 645
  • [9] Targeting abundant survivin expression in liposarcoma: subtype dependent therapy responses to YM155 treatment
    Christian Vay
    Philipp M. Schlünder
    Levent Dizdar
    Irene Esposito
    Markus P. H. Ghadimi
    Wolfram T. Knoefel
    Andreas Krieg
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 633 - 645
  • [10] Commitment toward cell death by activation of autophagy with survivin inhibitor YM155 in two canine squamous cell carcinoma cell lines with high expression of survivin
    Miyamoto, Ryo
    Tani, Hiroyuki
    Ikeda, Tomoyo
    Saima, Hono
    Tamura, Kyoichi
    Bonkobara, Makoto
    RESEARCH IN VETERINARY SCIENCE, 2021, 135 : 412 - 415
12345